Highlights from Biointron’s Lunch & Learn with MassBio: HTP antibody platforms, alpaca VHH discovery, bispecific antibodies, & ADC development advancements.

Biointron is excited to announce our participation in the Chinese Antibody Society 2024 Annual Meeting on May 11, 2024, in Cambridge, MA, USA. This premier event, themed "Beyond Borders: Advancements in Antibody-Based Therapeutics in Uncharted Territories," promises to showcase the latest developments in antibody therapeutics, with a focus on discovery, development, and manufacturing innovations.

The 4th Fc-Mediated Function Summit 2024 was held in Boston, MA from April 17-18, and focused on discussions supercharging FcRn, FcγR, and IgG to advance molecular development, clinical utility, and novel therapeutic applications.

​The AACR Annual Meeting 2024 was held in San Diego, CA from April 5-10, and featured the latest advancements in cancer research, with hundreds of poster presentations, lectures, and exhibits. Scientists, health care professionals, and industry experts from around the world gathered to share innovations and trends in oncology, including: Advances in Diagnostics and Therapeutics...

Here at the AACR Annual Meeting 2024, there are over 7000 abstracts, 300 poster presentations, and 50 symposia all about cancer research. A few topics that are currently trending in the conference include cancer vaccines, AI for diagnostics, novel immunotherapies, and antibody-drug conjugates (ADCs) as a new modality.

In March 2024, Cyagen and Biointron officially signed off on their strategic partnership, forging an alliance in antibody drug development. This partnership aims to fully leverage the strengths of Cyagen's HUGO-Ab™ fully humanized mouse antibody discovery platform and Biointron&#

Biointron is thrilled to be part of the 4th Fc-Mediated Function Summit, a pivotal event focusing on the latest developments in FcRn, FcγR, and IgG, aiming to enhance related therapeutic applications. This unique conference, happening in Boston from April 16-18, 2024, will be gathering over 80 specialists in the field to share insights on molecular engineering and clinical outcomes.

Biologics 2024 was held in London, UK, from March 13-15, and featured key opinion leaders, experts, and researchers in pharmaceuticals and biotech as well as academia. The event showcased the latest innovations and technological advancements in biologics discovery and development.The latest innovati

Antibody Engineering & Therapeutics Europe 2024, scheduled from June 4th to 6th at the Excel London Platinum Suite, represents a pivotal gathering for professionals in the realm of antibody and protein therapeutic science and technology. Biointron invites you to join us at booth number 24.

The BIO International Convention 2024, scheduled for June 3-6 in San Diego, CA, is set to be an exciting event for the biotechnology industry. Biointron is excited to be a part of this prestigious event. We invite you to visit our booth, number 1512.

The 23rd annual PepTalk, held from January 16-19, 2024, marked a significant gathering in the biotech and pharmaceutical field. The conference showcased the latest advancements in protein science and production, with illuminating keynote sessions.

We are thrilled to announce Biointron's participation in the 20th Annual PEGS Boston (The Protein Engineering Summit), happening from May 13-17, 2024, in Boston, MA. Organized by CHI, this summit is the epitome of innovation in protein and antibody engineering, a field where Biointron has continually demonstrated its leadership.

Celebrate the highlights from Biointron Year-End Networking, featuring industry insights, appreciation for partners & future biotech collaborations. Read the recap!